ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CYP2C9 and VKORC1 genotype-guided individualized warfarin therapy in Chinese patients with acute pulmonary thromboembolism: a randomized controlled clinical study

Jin, Heng*; Jiang, Feng; Wei, Jun; Yao, Ying; Yuan, Hengjie; Yu, Muming; Qi, Anlong; Chai, Yanfentianjin med univ
International Journal of Clinical and Experimental Medicine2017
11被引2阅读
引用收藏
分享

摘要

To investigate efficacy and safety of genotype-guided individualized anticoagulant therapy with warfarin for acute pulmonary thromboembolism (APTE) patients in Han Chinese. Patients enrolled were randomly divided into genotype-guided group and control group. The genotype of VKORC1 and CYP2C9 for all the patients was analyzed using PCR and biochip technology. The warfarin dosages in genotype-guided group on 1-3 days were determined by dosing algorithm on platform (http://www.warfarindosing.org), while the dosage in control group was 3 mg/24 h. From the 4th day, dosages were modulated according to international normalized ratio (INR) and clinical conditions. Therapy lasted for 12 weeks. Record INR values frequently. The average time to reach INR target range 2-3 (T-f) in genotype-guided group was significantly shorter compared with control group (P < 0.001). The average time to reach stable warfarin dosage (T-s) in genotype-guided group was significantly less than that of control group (P < 0.001). The percentage of patients reaching stable warfarin dose within 3 weeks (67.8%) was higher in genotyping-guided group than that in control group (P < 0.001). However, during weeks 4 to 12, it showed no significant difference except for week 5. Occurrence rate of INR > 4 and bleeding events showed no statistical difference. INR fluctuation (f(INR)) at initial therapy was more apparent in control group than that in genotype-guided group. CYP2C9 and VKORC1 genotype-guided method could be more efficient than normal dosing method. The data here supplied evidence for supporting the individual therapy of warfarin in clinic for Han Chinese.

学科与关键词

关键词
Genotype-guidedwarfarinCYP2C9VKORC1individualized anticoagulant therapypulmonary embolism
相关
加载中…
  • Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials
    Tang, Tao; Liu, Jie; Zuo, Keqiang; Cheng, Jie; Chen, Linyin; Lu, Chenhui; Han, Shilong; Xu, Jichong; Jia, Zhongzhi; Ye, Meng; Pei, Erli; Zhang, Xiaoping*; Li, MaoquanJOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 20(4): 387-394.被引 19
  • Warfarin pharmacogenetics
    Johnson, Julie A.*; Cavallari, Larisa H.Trends in Cardiovascular Medicine, 2015, 25(1): 33-41.被引 115
  • Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation
    Xu, Qiang; Xu, Bin; Zhang, Yuxiao; Yang, Jie; Gao, Lei; Zhang, Yan; Wang, Hongjuan; Lu, Caiyi; Zhao, Yusheng; Yin, Tong*Thrombosis and Haemostasis, 2012, 108(6): 1132-1140.被引 17
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Clinical and Experimental Medicine
发表日期
2017
卷期
第 10 卷, 第 3 期
页码
5595-5602
语言
ENGLISH
期刊等级
Q4
成果收录
SCIE
资助标注
Science and Technology Fund of Tianjin Municipal Health Bureau [2014KZ126]

作者

  • J

    Jin, Heng (通讯) (第一作者)

    tianjin med univ

  • J

    Jiang, Feng

    tianjin med univ

查看全部 8 位作者收起作者
  • W

    Wei, Jun

    tianjin med univ

  • Y

    Yao, Ying

    tianjin med univ

  • Y

    Yuan, Hengjie

    tianjin med univ

  • Y

    Yu, Muming

    tianjin med univ

  • Q

    Qi, Anlong

    tianjin med univ

  • C

    Chai, Yanfen

    tianjin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417